Kathy Wang is a senior regulatory affairs professional with a strong record in the medical device and combination product field. In her current position as a Regulatory Affairs Director, Devices and Digital Therapeutical at AstraZeneca, she supports the company in developing and marketing drug and device combined products. As a regulatory director, she provides regulatory strategy support to projects from pre-clinical phase to marketing and has extensive experience in the EU, US and China. Before joining AstraZeneca, she was responsible for the development and implementation of global regulatory strategies of implantable medical devices at Cochlear Ltd.